Kyndryl 10-Q: Material Weaknesses Persist, Operating Cash Flow Turns Negative $137M
KD sits 69% above its 52-week low of $10.1 on elevated volume (3.6× avg).
Summary
Kyndryl's Q2 10-Q shows net income of $59 million for the quarter but a $137 million operating cash outflow for the first half, with material weaknesses in internal controls still unremediated and remediation targeted for March 31, 2027.
Key Events · Earnings and Guidance · KD
-
Material Weaknesses Remain Unremediated
Disclosure controls and procedures were concluded not effective as of September 30, 2026 due to previously disclosed material weaknesses in the control environment, disclosure communication, and hotline escalation; management completed design and implementation of enhanced controls in Q2 FY2027 and is now testing operating effectiveness, targeting remediation as of March 31, 2027.
-
Operating Cash Flow Turns Negative
Net cash used in operating activities was $137 million for the six months ended September 30, 2026, versus $22 million provided a year earlier, driven by higher software payments of $187 million and the timing of advance customer billings.
-
Six-Month Net Income Collapses to $4M
Net income fell to $4 million from $124 million, as workforce rebalancing charges rose to $190 million from $44 million and impairment expense of $38 million was recorded, partly offset by a $40 million gain on the sale of a digital solutions subsidiary.
-
Healthcare IT Leaders Acquisition Closed
Kyndryl paid $307 million in cash plus contingent consideration fair-valued at $34 million (up to $40 million earnout) for the healthcare IT services provider, adding $170 million of intangibles and $132 million of goodwill.
Analysis · KD · Technology
Two items in Kyndryl's fiscal Q2 report go beyond the earnings press release: disclosure controls remain formally 'not effective' due to previously disclosed material weaknesses, and the business burned $137 million of operating cash in the first half versus generating $22 million a year ago. Six-month net income collapsed to $4 million from $124 million as workforce rebalancing charges jumped to $190 million from $44 million. Management says it has finished designing and implementing the remediation controls and is now testing them, targeting remediation by March 31, 2027 — until that is certified, the control overhang and the SEC investigation into cash management practices stay live. The quarter itself was fine — $59 million of net income and $699 million of adjusted EBITDA — but the cash burn and the unresolved controls are what investors will focus on.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KD was trading at $17.03 on NYSE in the Technology sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $10.10 to $28.83. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.